Evidence map›Paper›PMID 28074003›Full record

ArticleMolecular cancer research : MCR2017

DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin Therapy.

Antonia A Nemec, Laura Abriola, Jane S Merkel, Elisa de Stanchina, Michelle DeVeaux, Daniel Zelterman, Peter M Glazer, Joann B Sweasy

Abstract read
In one paragraph

Article in Molecular cancer research : MCR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The Role of Natural Polymorphic Variants of DNA Polymerase β in DNA Repair.International journal of molecular sciences · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Analysis of DNA Polymerases Reveals Specific Genes Expansion inFrontiers in cellular and infection microbiology · 2020
    Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Antonia A NemecDepartment of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut. antonia.nemec@med.fsu.edu joann.sweasy@yale.edu.
Laura AbriolaCenter for Molecular Discovery, Yale University, West Haven, Connecticut.
Jane S MerkelCenter for Molecular Discovery, Yale University, West Haven, Connecticut.
Elisa de StanchinaAntitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, New York.
Michelle DeVeauxDepartment of Biostatistics, Yale University School of Public Health, New Haven, Connecticut.
Daniel ZeltermanDepartment of Biostatistics, Yale University School of Public Health, New Haven, Connecticut.
Peter M GlazerDepartment of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut.
Joann B SweasyDepartment of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut. antonia.nemec@med.fsu.edu joann.sweasy@yale.edu.
Yale University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI DAVID L RIMM · 1985 to 2026
$85.0M
MSKCC Pilot Center for Precision Disease ModelingU54OD020355 · OD · SLOAN-KETTERING INST CAN RESEARCH · PI LOWE, SCOTT W., SOLIT, DAVID B. · 2015 to 2019
$9.9M
DNA Polymerase Beta Variants and CancerR01ES019179 · NIEHS · YALE UNIVERSITY · PI SWEASY, JOANN B. · 2010 to 2020
$3.9M
NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016359NIEHS NIH HHS R01 ES019179NIH HHS U54 OD020355
6 · The paper itself

Abstract

Resistance to cancer chemotherapies leads to deadly consequences, yet current research focuses only on the roles of somatically acquired mutations in this resistance. The mutational status of the germline is also likely to play a role in the way cells respond to chemotherapy. The carrier status for the

Indexed as

Germ-Line MutationA549 CellsAnimalsAntineoplastic AgentsCisplatinDNA Mismatch RepairDNA Polymerase betaDrug Resistance, NeoplasmHCT116 CellsHumansMCF-7 CellsMiceNeoplasmsXenograft Model Antitumor AssaysAntineoplastic AgentsCisplatinDNA Polymerase beta

Identifiers

PMID28074003
PMCPMC5334281
OpenAlexW2570110612

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.